Qigui Yu
Immunology and Microbiology · Indiana University
Publications
123
Citations
2,164
Est. group size
—
Recurring co-author estimate
Active years
38
Publishing since 1988
Qigui Yu conducts research in immunology and microbiology, studying how the immune system responds to infections and inflammatory conditions. Recent work spans HIV infection and immune cell depletion, bacterial molecular patterns that trigger antiviral immune responses (such as those from the Lyme disease bacterium Borrelia burgdorferi), and inflammation in diseases like alcoholic hepatitis, sickle cell disease, and traumatic brain injury. The publication record also includes some collaborative papers in unrelated technical fields.
Publication activity has been relatively steady over the last decade, averaging around 4-6 papers per year in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
7 earlier awards
- NIH R56NS129438Aug 2023 – Aug 2025 · $824k awarded
Immune checkpoints in the CNS and HIV-associated neurocognitive disorder
- NIH UH3AA026218Sep 2017 – Aug 2024 · $302k awarded
Alcohol's impact on immunological and virological profiles in HIV patients
- NIH R01AI117835Feb 2015 – Feb 2020 · $386k awarded
Targeting latently infected Tfh cells to achieving a functional cure of HIV-1
- NIH UH2AA026218Sep 2017 – Aug 2019 · $153k awarded
Alcohol's impact on immunological and virological profiles in HIV patients
- NIH R33AI104268Dec 2012 – May 2019 · $386k awarded
Specific killing of latently HIV-1-infected cells after provirus reactivation
- NIH R21AI104268Dec 2012 – Mar 2015 · $234k awarded
Specific killing of latently HIV-1-infected cells after provirus reactivation
- NIH R21AI073250Sep 2007 – Aug 2010 · $189k awarded
Development of Molecular Adjuvants for Therapeutic HIV-1 Vaccines
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~8 · 6% small-team papers (≤3 authors) · across 30 venues
- Enhancing the performance of quantum radar with zero-photon subtraction
Physical review. A/Physical review, A · 2025
- A StationXML-Based Platform for Seismic Station Metadata Management and Services
2025
- Borrelia burgdorferi c-di-AMP is a key extracellular pathogen-associated molecular pattern to elicit type I interferon responses in mammalian hosts
The Journal of Immunology · 2025
- Acupuncture Ameliorates Heightened Inflammatory/Immune Responses Accompanied with Improvement in Clinical Outcomes in Patients with Sickle Cell Disease
Blood · 2024
- Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis
Frontiers in Immunology · 2024
- Peripheral mucosal-associated invariant T (MAIT) cells are severely depleted in HIV-positive heavy alcohol users
The Journal of Immunology · 2024
- Borrelia burgdorferi Secretes c-di-AMP as an Extracellular Pathogen-Associated Molecular Pattern to Elicit Type I Interferon Responses in Mammalian Hosts
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- AB0116 EVALUATING THE IMPACT OF METFORMIN TARGETS ON THE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS: A MENDELIAN RANDOMIZATION STUDY
Annals of the Rheumatic Diseases · 2023
- AB0346 INTESTINAL MICROECOLOGICAL DISORDERS IN RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases · 2023
- AB0088 GENETICALLY DETERMINED GUT MICROBIOME AND THE RISK OF ANKYLOSING SPONDYLOARTHRITIS
2023
- Identifying Inflammatory and Immune Markers Associated with Vasoocclusive Crisis in Patients with Sickle Cell Disease
Blood · 2023
- Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis
medRxiv · 2023
- PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury
Journal of Neuroinflammation · 2022
- Cell‐to‐cell transmission of HIV‐1 from provirus‐activated cells to resting naïve and memory human primary CD4 T cells is highly efficient and requires CD4 and F‐actin but not chemokine receptors
Journal of Medical Virology · 2022
- The Impacts of COVID-19 on Musculoskeletal Health
Current Osteoporosis Reports · 2022
- medRxiv×5
- Author eBooks×4
- Frontiers in Immunology×3
- The Journal of Immunology×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Alka Khaitan
Immunology and Microbiology · Indiana University
- Qigui Yu
Immunology and Microbiology · Indiana University
- Kathleen L. Collins
Immunology and Microbiology · University of Michigan
- Jennie L. Lovett
Immunology and Microbiology · University of Michigan
- Thomas Decoville
Immunology and Microbiology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile